ArticleCureus2025
High-Frequency Accessory and Transcapular Nerve Blocks in the Management of Fibromyalgia: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This is the first case report describing the effect of weekly accessory nerve and transcapular nerve blocks for managing fibromyalgia (FM)-related pain in a 45-year-old female patient. The diagnosis was established using the new American College of Rheumatologist criteria. Following diagnosis, bilateral accessory and transcapular nerve blocks were administered using Xylocaine. In this particular patient, the nerve blocks decreased the numeric rating scale from 9 to 2 after treatment in the same visit, improved the benefits of daily activities, and improved tolerance of physical activities in six months. The patient reported significant improvement in pain, supporting the hypothesis that interventional management, like nerve blocks, may reduce peripheral nociceptive input and mitigate central sensitization, a hallmark of FM. The findings of this case report suggest that targeted nerve blocks can serve as a complementary treatment for FM-related neck and shoulder pain, particularly in cases involving myofascial trigger points in the trapezius and infraspinatus muscles. By integrating accessory and transcapular nerve blocks with existing multidisciplinary management approaches, clinicians can offer more options for pain management for FM patients with neck and shoulder pain. However, future randomized controlled trials are essential for cause-effect relationships and optimizing nerve block treatment protocols to support evidence-based practices and better patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.